Because this was an exploratory study in persons not hospitalized with minor symptoms from COVID-19, we limited our investigation to the plasma biomarkers tau, GFAP, NfL, and UCHL1 and compared their biomarker levels to a small cohort of healthy controls whose plasma was obtained before the beginning of the COVID-19 outbreak in North Carolina. The gene discussed is MAPT; the disease is COVID-19.